Cara Therapeutics Inc (NAS:CARA)
$ 0.2702 -0.0233 (-7.94%) Market Cap: 14.82 Mil Enterprise Value: -33.03 Mil PE Ratio: 0 PB Ratio: 1.39 GF Score: 31/100

Q4 2022 Cara Therapeutics Inc Earnings Call Transcript

Mar 06, 2023 / 09:30PM GMT
Release Date Price: $10.02 (-2.53%)
Operator

Good afternoon. My name is Josh, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Update Conference Call. (Operator Instructions) Please be advised that this call is being recorded.

I would now like to introduce Matt Murphy, Cara's Manager of Investor Relations. Mr. Murphy, you may begin your call.

Matthew Murphy
Cara Therapeutics, Inc. - Manager of IR

Thank you, operator, and good afternoon. Just after market close today, Cara issued a news release announcing the company's results for the fourth quarter and full year 2022. Copies of this news release and the associated SEC filing can be found in the Investors section of our website at www.caratherapeutics.com.

Before we begin, let me remind you that during the course of this conference call, we will be making certain forward-looking statements about Cara and our programs based on management's current plans and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot